Search Results for “” – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Project:ACT Guided Heparinization

Categories:Clinical outcomes

12 Publications found

Weight Based Heparin Dosage with Activated Clotting Time Monitoring Leads to Adequate and Safe Anticoagulation in Non-Cardiac Arterial Procedures.

b

Annals of vascular surgery

August 1, 2022

p ACT Guided Heparinization

c Change patient management Clinical outcomes Observational Safety
Routine fixed-dose heparin vs. ACT-guided heparin administration for elective PCI and its influence on patient in-hospital outcome: a retrospective study.

b

Coronary artery disease

September 1, 2021

p ACT Guided Heparinization

c Change patient management Clinical outcomes Observational Safety
Appropriate intraprocedural initial heparin dosing in patients undergoing catheter ablation for atrial fibrillation receiving uninterrupted non-vitamin-K antagonist oral anticoagulant treatment.

b

BMC cardiovascular disorders

April 27, 2021

p ACT Guided Heparinization

c Change patient management Clinical outcomes RCT Safety
Heparin sensitivity and postoperative blood loss in patients undergoing cardiac surgery with cardiopulmonary bypass.

b

European journal of anaesthesiology

March 1, 2020

p ACT Guided Heparinization

c Change patient management Clinical outcomes Observational Safety
Adjusted calculation model of heparin management during cardiopulmonary bypass in obese patients: A randomised controlled trial.

b

European journal of anaesthesiology

August 1, 2018

p ACT Guided Heparinization

c Change patient management Clinical outcomes RCT
Activated Clotting Time to Guide Heparin Dosing in Non-ST-Segment-Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors: Impact on Ischemic and Bleeding Outcomes: Insights From the TAO Trial.

b

Circulation. Cardiovascular interventions

June 1, 2018

p ACT Guided Heparinization

c Change patient management Clinical outcomes Highlighted Observational Safety
An Adjusted Calculation Model of Reduced Heparin Doses in Cardiopulmonary Bypass Surgery in a Chinese Population.

b

Journal of cardiothoracic and vascular anesthesia

October 1, 2016

p ACT Guided Heparinization

c Change patient management Clinical outcomes Observational Safety
Off-pump coronary artery bypass grafting using continuous heparin infusion.

b

Indian heart journal

January 1, 2016

p ACT Guided Heparinization

c Change patient management Clinical outcomes Observational Safety
Activated clotting time and outcomes during percutaneous coronary intervention for non-ST-segment-elevation myocardial infarction: insights from the FUTURA/OASIS-8 Trial.

b

Circulation. Cardiovascular interventions

April 1, 2015

p ACT Guided Heparinization

c Change patient management Clinical outcomes Highlighted RCT Safety
Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation.

b

The Annals of pharmacotherapy

March 1, 2015

p ACT Guided Heparinization

c Change patient management Clinical outcomes Highlighted Observational Safety